Abstract
Advanced therapies, including cell and gene therapies, have shown therapeutic promise in curing life-threatening diseases such as leukaemia and lymphoma. However, they can be complicated and expensive to deliver due to their sensitivity to environment, troublesome tissue, cell, or genetic material sourcing and complicated regulatory requirements.
| Original language | English |
|---|---|
| Pages (from-to) | 0-0 |
| Number of pages | 0 |
| Journal | JMIR Research Protocols |
| Volume | 9 |
| Issue number | 12 |
| Early online date | 14 Dec 2020 |
| DOIs | |
| Publication status | Published - 14 Dec 2020 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
-
SDG 9 Industry, Innovation, and Infrastructure
Fingerprint
Dive into the research topics of 'Developing a blockchain-based supply chain system for advanced therapies: study protocol'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver